These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7387628)

  • 21. Reaction products of styrene oxide with guanosine in aqueous media.
    Hemminki K; Hesso A
    Carcinogenesis; 1984 May; 5(5):601-7. PubMed ID: 6722980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
    Eagan RT; Creagan ET; Bisel HF; Layton DD; Groover RV; Herman RC
    Oncology; 1981; 38(1):4-6. PubMed ID: 7443176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactions of beta-propiolactone, beta-butyrolactone and gamma-butyrolactone with nucleic acids.
    Hemminki K
    Chem Biol Interact; 1981 Mar; 34(3):323-31. PubMed ID: 6161710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivatives of 2,3-anhydro-DL-threitol, 2,3-anhydroerythritol, 2,3:4,5-dianhydrogalactitol, and 2,3:4,5-dianhydroallitol.
    Schneider G; Horváth T; Sohár P
    Carbohydr Res; 1977 Jun; 56(1):43-52. PubMed ID: 880588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alkylation of guanosine and 4-(p-nitrobenzyl)-pyridine by styrene oxide analogues in vitro.
    Hemminki K; Heinonen T; Vainio H
    Arch Toxicol; 1981 Nov; 49(1):35-41. PubMed ID: 7325798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alkylation of guanosine and deoxyguanosine by phosphoramide mustard.
    Mehta JR; Przybylski M; Ludlum DB
    Cancer Res; 1980 Nov; 40(11):4183-6. PubMed ID: 7471059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dianhydrogalactitol in the treatment of children with primary brain tumors.
    Weinblatt ME; Ortega JA; Giggins GR; Siegel SE
    Cancer Treat Rep; 1981; 65(9-10):923-4. PubMed ID: 7273030
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of dianhydrogalactitol in malignant glioma.
    Espana P; Wiernik PH; Walker MD
    Cancer Treat Rep; 1978 Aug; 62(8):1199-200. PubMed ID: 210944
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigation of 6-thiodeoxyguanosine alkylation products and their role in the potentiation of BCNU cytotoxicity.
    Bodell WJ
    IARC Sci Publ; 1986; (70):147-54. PubMed ID: 3793170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy].
    Fan YJ; Zhou J; Li M
    Yao Xue Xue Bao; 1983 Sep; 18(9):648-53. PubMed ID: 6677049
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
    Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
    Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
    Vats TS; Lui V; Trueworthy R; van Eys J
    Cancer Treat Rep; 1981; 65(1-2):121-2. PubMed ID: 6939482
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD; Baker L; Thigpen T
    Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomas.
    Edmonson JH; Frytak S; Letendre L; Kvols LK; Eagan RT
    Cancer Treat Rep; 1979; 63(11-12):2081-3. PubMed ID: 526941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic retinoblastoma and L-phenylalanine mustard-dianhydrogalactitol.
    Helson L; Kitchin FD; Abramson D; Ellsworth RM
    Anticancer Res; 1982; 2(4):235-8. PubMed ID: 7149653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of 1,2:5,6-dianhydrogalactitol on the bone marrow stem cells in normal and melanoma-bearing mice (author's transl)].
    Fan YJ; Li M; Zhou J
    Zhongguo Yao Li Xue Bao; 1980 Dec; 1(2):112-5. PubMed ID: 6461181
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Finklestein JZ; Shore N; Krivit W; Hammond D; Higgins G
    Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
    [No Abstract]   [Full Text] [Related]  

  • 39. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract]   [Full Text] [Related]  

  • 40. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
    Vogl SE; Seltzer V; Camacho F; Calanog A
    Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.